Joint Venture6 Nov 2025, 10:58 am
Co-Diagnostics Engages Maxim for CoSara Diagnostics' SPAC Transaction
AI Summary
Co-Diagnostics, Inc., a joint venture partner in CoSara Diagnostics Pvt. Ltd., has engaged Maxim Group to pursue a Special Purpose Acquisition Company (SPAC) transaction for CoSara. CoSara Diagnostics is a joint venture between Ambalal Sarabhai Enterprises Limited and Co-Diagnostics, Inc. The aim is to unlock value for CoSara and its shareholders, and to help CoSara fully realize its founding vision. CoSara, established in 2017, intends to manufacture and sell molecular diagnostics products to patients and healthcare providers in certain international markets with an initial focus on India.
Key Highlights
- Co-Diagnostics engages Maxim Group to pursue SPAC transaction for CoSara Diagnostics
- CoSara Diagnostics is a joint venture between Ambalal Sarabhai Enterprises Limited and Co-Diagnostics, Inc.
- The aim of the SPAC transaction is to unlock value for CoSara and its shareholders
- CoSara was established in 2017 with an initial focus on the Indian market
- CoSara intends to manufacture and sell molecular diagnostics products